Dr. Jinnette D. Abbott, MD
Interventional Cardiology (Interventional Cardiology Physician)
2 Dudley St, Suite 360
Providence, RI 02905
Who else practices at this address →
Providence County includes mental health (6% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- University of Chicago, Pritzker School of Medicine (1995)
- Years since graduation
- 31
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 691
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1995Medical school: University of Chicago, Pritzker School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Interventional Cardiology Physician primary
RI license 11487 -
Cardiovascular Disease Physician
RI license MD11487
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- The Miriam Hospital Providence, RI
- Rhode Island Hospital Providence, RI
- Newport Hospital Newport, RI
- South County Hospital Inc Wakefield, RI
Medical groups
- Lifespan Physician Group Inc (1,173 clinicians)
- The Miriam Hospital (172 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 691
- Services billed
- 1,377
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 154 | 150 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 143 | 140 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 129 | 120 |
| Ultrasound of both sides of head and neck blood flow | 97 | 97 |
| Critical care, first 30-74 minutes | 70 | 37 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 65 | 65 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 57 | 56 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 57 | 32 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 53 | 51 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 52 | 41 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Atorvastatin Calcium Other prescribers in Providence, RI | 454 |
| Metoprolol Succinate Other prescribers in Providence, RI | 404 |
| Rosuvastatin Calcium Other prescribers in Providence, RI | 264 |
| Losartan Potassium Other prescribers in Providence, RI | 228 |
| Lisinopril Other prescribers in Providence, RI | 198 |
| Amlodipine Besylate Other prescribers in Providence, RI | 195 |
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Providence, RI | 183 |
| Furosemide Other prescribers in Providence, RI | 175 |
| Metoprolol Tartrate Other prescribers in Providence, RI | 171 |
| Eliquis (apixaban) Other prescribers in Providence, RI | 158 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 5 companies reported 25 payments worth $20,313 in total to this clinician.
| Medtronic, Inc. | $10,007 |
|---|---|
| Boston Scientific Corporation | $6,906 |
| Abbott Laboratories | $3,096 |
| Shockwave Medical, Inc | $181 |
| Zoll Services LLC (a/k/a Zoll Lifecor Corp) | $122 |
| Compensation for services other than consulting (speaking, faculty) | $8,625 |
|---|---|
| Consulting Fee | $8,500 |
| Travel and Lodging | $2,051 |
| Food and Beverage | $1,138 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Medtronic, Inc. Sep 4, 2025 | Compensation for services other than consulting (speaking, faculty) ONYX FRONTIER · Stents | $8,625 |
| Boston Scientific Corporation Apr 24, 2025 | Consulting Fee General - Balloons · General - Balloons_PI | $5,500 |
| Abbott Laboratories Dec 10, 2025 | Consulting Fee OPTIS · Structural Heart | $3,000 |
| Medtronic, Inc. Jul 31, 2025 | Travel and Lodging ONYX FRONTIER · Stents · travel to Minneapolis, MN · in-kind | $768 |
| Boston Scientific Corporation Apr 4, 2025 | Travel and Lodging AVVIGO Guidance System · AVVIGO_IC · travel to Minneapolis, MN · in-kind | $647 |
| Boston Scientific Corporation Apr 4, 2025 | Travel and Lodging AVVIGO Guidance System · AVVIGO_IC · travel to Minneapolis, MN · in-kind | $240 |
| Medtronic, Inc. Aug 18, 2025 | Travel and Lodging ONYX FRONTIER · Stents · travel to Minneapolis, MN · in-kind | $219 |
| Medtronic, Inc. Aug 19, 2025 | Travel and Lodging ONYX FRONTIER · Stents · travel to Minneapolis, MN · in-kind | $48.80 |
| Medtronic, Inc. Aug 4, 2025 | Travel and Lodging ONYX FRONTIER · Stents · travel to Minneapolis, MN · in-kind | $35.07 |
| Medtronic, Inc. Sep 8, 2025 | Travel and Lodging ONYX FRONTIER · Stents · travel to Minneapolis, MN · in-kind | $34.95 |
All 13 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Abbott Laboratories Dec 10, 2025 | Consulting Fee OPTIS · Structural Heart | $3,000 |
| Medtronic, Inc. Sep 8, 2025 | Travel and Lodging ONYX FRONTIER · Stents · travel to Minneapolis, MN · in-kind | $34.95 |
| Medtronic, Inc. Sep 4, 2025 | Compensation for services other than consulting (speaking, faculty) ONYX FRONTIER · Stents | $8,625 |
| Medtronic, Inc. Aug 19, 2025 | Travel and Lodging ONYX FRONTIER · Stents · travel to Minneapolis, MN · in-kind | $48.80 |
| Medtronic, Inc. Aug 19, 2025 | Travel and Lodging ONYX FRONTIER · Stents · travel to Minneapolis, MN · in-kind | $16.89 |
| Medtronic, Inc. Aug 19, 2025 | Travel and Lodging ONYX FRONTIER · Stents · travel to Minneapolis, MN · in-kind | $11.27 |
| Medtronic, Inc. Aug 18, 2025 | Travel and Lodging ONYX FRONTIER · Stents · travel to Minneapolis, MN · in-kind | $219 |
| Medtronic, Inc. Aug 18, 2025 | Travel and Lodging ONYX FRONTIER · Stents · travel to Minneapolis, MN · in-kind | $29.64 |
| Medtronic, Inc. Aug 4, 2025 | Travel and Lodging ONYX FRONTIER · Stents · travel to Minneapolis, MN · in-kind | $35.07 |
| Medtronic, Inc. Jul 31, 2025 | Travel and Lodging ONYX FRONTIER · Stents · travel to Minneapolis, MN · in-kind | $768 |
| Boston Scientific Corporation Apr 24, 2025 | Consulting Fee General - Balloons · General - Balloons_PI | $5,500 |
| Boston Scientific Corporation Apr 4, 2025 | Travel and Lodging AVVIGO Guidance System · AVVIGO_IC · travel to Minneapolis, MN · in-kind | $647 |
| Boston Scientific Corporation Apr 4, 2025 | Travel and Lodging AVVIGO Guidance System · AVVIGO_IC · travel to Minneapolis, MN · in-kind | $240 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 7 industry-funded studies in 2025, from 6 companies. The companies reported $35,051 in research payments for these studies, mostly to the institutions running them.
- Prevail Global
Medtronic, Inc. - A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR)
Boston Scientific Corporation · Active, not recruiting · NCT04647253 - A Prospective Randomized Single Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 Drug Eluting Balloon in the Treatment of Subjects With In-stent Restenosis
M.a. Med Alliance S.a. - Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial
Abbott Laboratories · Active, not recruiting · NCT03108456 - Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery Disease
Shockwave Medical, Inc - RADIANCE HTN
Recor Medical Inc - RADIANCE CAP
Recor Medical Inc
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.